Key facts
- This page summarizes Patrick Plewman's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 7 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Nov 2026, 19:13.
Patrick Plewman - 09 Nov 2026 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP for Diagnostic Services
- Issuer ticker
- DGX
- Reported as of
- 09 Nov 2026
- Net transaction value
- -$3,015,253
- SEC form
- 4
- Accepted by SEC
- 12 Nov 2026, 19:13:37 UTC
- Prior SEC filing
- 23 Oct 2026
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for Patrick Plewman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Patrick Plewman filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 12 Nov 2026.
Change
- Previous filing in this sequence was filed on 23 Oct 2026.
- Current net transaction value: -$3,015,253.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001497368
Primary reporting owner
Plewman Patrick
- Relationship
- SVP for Diagnostic Services
- Address
- 500 PLAZA DRIVE, C/O QUEST DIAGNOSTICS INC, SECAUCUS
- Signature
- Sean D. Mersten, Attorney in Fact for Patrick Plewman
- Signature date
- 12 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,274
- Change %
- +28%
- Price
- $127.72*
- Shares after
- 19,608
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Sale
- Transaction value
- -$1,099,871
- Shares
- -4,274
- Change %
- -22%
- Price
- $257.34
- Shares after
- 15,334
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +6,793
- Change %
- +44%
- Price
- $127.80*
- Shares after
- 22,127
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Sale
- Transaction value
- -$1,748,111
- Shares
- -6,793
- Change %
- -31%
- Price
- $257.34
- Shares after
- 15,334
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Sale
- Transaction value
- -$167,271
- Shares
- -650
- Change %
- -4.2%
- Price
- $257.34
- Shares after
- 14,684
- Date
- 09 Nov 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DGX
transaction
Derivative
Non-Qualifed Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -4,274
- Change %
- -100%
- Price
- $127.72*
- Shares after
- 0
- Date
- 09 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,274
- Exercise price
- $127.72
- Footnotes
- F1, F3
DGX
transaction
Derivative
Non-Qualifed Stock Option (right to buy)
Options Exercise
- Transaction value
- Shares
- -6,793
- Change %
- -67%
- Price
- $127.80*
- Shares after
- 3,397
- Date
- 09 Nov 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,793
- Exercise price
- $127.80
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Footnote F2
The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
Footnote F3
The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.